Correction: Naunyn-Schmiedeberg's Archives of Pharmacology (2019) 392:633-640

https://doi.org/10.1007/s00210-019-01619-0

The authors recently discovered an unintentional error in the selection of images for Fig. 3, specifically for the sham and BL (5) groups. Both images, unfortunately, pertained to the BL (5) group, leading to an overlap in Figure 3 between the sham and BL (5) images. This error occurred because the images for the sham and BL (5) groups were mistakenly placed in the same folder, leading to confusion during the final image selection process. We deeply apologize for any confusion or misinterpretation it may have caused. To ensure the validity and rigor of our research results, we request a correction to the image in Fig. 3 for the sham group. It is crucial to emphasize that this correction pertains solely to the sham group image, and the replacement will not impact the overall results or conclusions presented in the paper. The corrected Fig. 3 is depicted below.

Fig. 3
figure a

H&E-stained sections of the renal tissues. Sham, healthy mice receiving the vehicles; BL (5), healthy mice receiving 5 mg/kg β-lapachone; DOX, mice receiving only 20 mg/kg doxorubicin; DOX + BL (1.25), mice receiving 20 mg/kg doxorubicin and 1.25 mg/kg β-lapachone; DOX + BL (2.5), mice receiving 20 mg/kg doxorubicin and 2.5 mg/kg B-lapachone; DOX + BL (5), mice receiving 20 mg/kg doxorubicin and 5 mg/kg β-lapachone